About us
Out of complexity we create precision
Owkin is an AI Biotech that uses AI to unlock complex biology to find the right treatment for every patient
Our story
Transforming drug discovery and development
Owkin was founded by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, PhD, a pioneer in the field of machine learning in biology, in 2016.
We use AI to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes.
Owkin at a glance
A diverse multidisciplinary team
357
Team
92
PhDs
23
Languages
40
/
60
Female/male*
Our multidisciplinary team have expertise across machine learning, statistics, medicine, and biology.
*For the year 2022, Owkin’s score for the “Professional Equality Index” in France, is 93/100. This index measure wage equality between women and men within the company.